A thing worthy of mention:
In my last appointment with Dr. Thompson, after my blood work came back normal (as has become routine) I was shaking my head asking "what now? The 'talk show' circuit?" He told me that the study I'm involved with hasn't been around that long, so getting accurate numbers on how this drug is fairing as a cancer treatment modality is difficult. For one thing, if you imagine this as a bell curve, where the highest number of people receive the maximum amount of protection from disease progression at the highest point of the curve, it was expected that the line would taper down the other side of the curve until it touched the "x" axis (meaning that it had stopped working for everyone who has ever taken it). What they're finding out is that the line on the back side of the bell curve does indeed slope toward the x-axis, but it hasn't touched yet. Me and a handful of others are responding long term, perhaps 50-100 people nationwide. Perhaps I should start buying lottery tickets...
In my last appointment with Dr. Thompson, after my blood work came back normal (as has become routine) I was shaking my head asking "what now? The 'talk show' circuit?" He told me that the study I'm involved with hasn't been around that long, so getting accurate numbers on how this drug is fairing as a cancer treatment modality is difficult. For one thing, if you imagine this as a bell curve, where the highest number of people receive the maximum amount of protection from disease progression at the highest point of the curve, it was expected that the line would taper down the other side of the curve until it touched the "x" axis (meaning that it had stopped working for everyone who has ever taken it). What they're finding out is that the line on the back side of the bell curve does indeed slope toward the x-axis, but it hasn't touched yet. Me and a handful of others are responding long term, perhaps 50-100 people nationwide. Perhaps I should start buying lottery tickets...